Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1996 Oct;149(4):1081–1086.

Rous-Whipple Award Lecture. Role of complement in lung inflammatory injury.

P A Ward 1
PMCID: PMC1865199  PMID: 8863656

Full text

PDF
1079

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Craddock P. R., Fehr J., Dalmasso A. P., Brighan K. L., Jacob H. S. Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest. 1977 May;59(5):879–888. doi: 10.1172/JCI108710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Foreman K. E., Vaporciyan A. A., Bonish B. K., Jones M. L., Johnson K. J., Glovsky M. M., Eddy S. M., Ward P. A. C5a-induced expression of P-selectin in endothelial cells. J Clin Invest. 1994 Sep;94(3):1147–1155. doi: 10.1172/JCI117430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Frank M. M., Fries L. F. The role of complement in inflammation and phagocytosis. Immunol Today. 1991 Sep;12(9):322–326. doi: 10.1016/0167-5699(91)90009-I. [DOI] [PubMed] [Google Scholar]
  4. Gerard C., Gerard N. P. C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu Rev Immunol. 1994;12:775–808. doi: 10.1146/annurev.iy.12.040194.004015. [DOI] [PubMed] [Google Scholar]
  5. Gerard N. P., Hodges M. K., Drazen J. M., Weller P. F., Gerard C. Characterization of a receptor for C5a anaphylatoxin on human eosinophils. J Biol Chem. 1989 Jan 25;264(3):1760–1766. [PubMed] [Google Scholar]
  6. Haslam P. L., Townsend P. J., Branthwaite M. A. Complement activation during cardiopulmonary bypass. Anaesthesia. 1980 Jan;35(1):22–26. doi: 10.1111/j.1365-2044.1980.tb03715.x. [DOI] [PubMed] [Google Scholar]
  7. Hattori R., Hamilton K. K., McEver R. P., Sims P. J. Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem. 1989 May 25;264(15):9053–9060. [PubMed] [Google Scholar]
  8. Hänsch G. M., Seitz M., Betz M. Effect of the late complement components C5b-9 on human monocytes: release of prostanoids, oxygen radicals and of a factor inducing cell proliferation. Int Arch Allergy Appl Immunol. 1987;82(3-4):317–320. doi: 10.1159/000234216. [DOI] [PubMed] [Google Scholar]
  9. Johnson A. R., Hugli T. E., Müller-Eberhard H. J. Release of histamine from rat mast cells by the complement peptides C3a and C5a. Immunology. 1975 Jun;28(6):1067–1080. [PMC free article] [PubMed] [Google Scholar]
  10. Johnson K. J., Ward P. A. Acute immunologic pulmonary alveolitis. J Clin Invest. 1974 Aug;54(2):349–357. doi: 10.1172/JCI107770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kilgore K. S., Shen J. P., Miller B. F., Ward P. A., Warren J. S. Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1. J Immunol. 1995 Aug 1;155(3):1434–1441. [PubMed] [Google Scholar]
  12. Lozada C., Levin R. I., Huie M., Hirschhorn R., Naime D., Whitlow M., Recht P. A., Golden B., Cronstein B. N. Identification of C1q as the heat-labile serum cofactor required for immune complexes to stimulate endothelial expression of the adhesion molecules E-selectin and intercellular and vascular cell adhesion molecules 1. Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8378–8382. doi: 10.1073/pnas.92.18.8378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Meuer S., Ecker U., Hadding U., Bitter-Suermann D. Platelet-serotonin release by C3a and C5a: two independent pathways of activation. J Immunol. 1981 Apr;126(4):1506–1509. [PubMed] [Google Scholar]
  14. Mulligan M. S., Desrochers P. E., Chinnaiyan A. M., Gibbs D. F., Varani J., Johnson K. J., Weiss S. J. In vivo suppression of immune complex-induced alveolitis by secretory leukoproteinase inhibitor and tissue inhibitor of metalloproteinases 2. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11523–11527. doi: 10.1073/pnas.90.24.11523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mulligan M. S., Paulson J. C., De Frees S., Zheng Z. L., Lowe J. B., Ward P. A. Protective effects of oligosaccharides in P-selectin-dependent lung injury. Nature. 1993 Jul 8;364(6433):149–151. doi: 10.1038/364149a0. [DOI] [PubMed] [Google Scholar]
  16. Mulligan M. S., Polley M. J., Bayer R. J., Nunn M. F., Paulson J. C., Ward P. A. Neutrophil-dependent acute lung injury. Requirement for P-selectin (GMP-140). J Clin Invest. 1992 Oct;90(4):1600–1607. doi: 10.1172/JCI116029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mulligan M. S., Schmid E., Beck-Schimmer B., Till G. O., Friedl H. P., Brauer R. B., Hugli T. E., Miyasaka M., Warner R. L., Johnson K. J. Requirement and role of C5a in acute lung inflammatory injury in rats. J Clin Invest. 1996 Jul 15;98(2):503–512. doi: 10.1172/JCI118818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mulligan M. S., Smith C. W., Anderson D. C., Todd R. F., 3rd, Miyasaka M., Tamatani T., Issekutz T. B., Ward P. A. Role of leukocyte adhesion molecules in complement-induced lung injury. J Immunol. 1993 Mar 15;150(6):2401–2406. [PubMed] [Google Scholar]
  19. Mulligan M. S., Vaporciyan A. A., Miyasaka M., Tamatani T., Ward P. A. Tumor necrosis factor alpha regulates in vivo intrapulmonary expression of ICAM-1. Am J Pathol. 1993 Jun;142(6):1739–1749. [PMC free article] [PubMed] [Google Scholar]
  20. Mulligan M. S., Wilson G. P., Todd R. F., Smith C. W., Anderson D. C., Varani J., Issekutz T. B., Miyasaka M., Tamatani T., Myasaka M. Role of beta 1, beta 2 integrins and ICAM-1 in lung injury after deposition of IgG and IgA immune complexes. J Immunol. 1993 Mar 15;150(6):2407–2417. [PubMed] [Google Scholar]
  21. Mulligan M. S., Yeh C. G., Rudolph A. R., Ward P. A. Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury. J Immunol. 1992 Mar 1;148(5):1479–1485. [PubMed] [Google Scholar]
  22. Murphy H. S., Maroughi M., Till G. O., Ward P. A. Phorbol-stimulated influx of extracellular calcium in rat pulmonary artery endothelial cells. Am J Physiol. 1994 Aug;267(2 Pt 1):L145–L151. doi: 10.1152/ajplung.1994.267.2.L145. [DOI] [PubMed] [Google Scholar]
  23. Murphy H. S., Shayman J. A., Till G. O., Mahrougui M., Owens C. B., Ryan U. S., Ward P. A. Superoxide responses of endothelial cells to C5a and TNF-alpha: divergent signal transduction pathways. Am J Physiol. 1992 Jul;263(1 Pt 1):L51–L59. doi: 10.1152/ajplung.1992.263.1.L51. [DOI] [PubMed] [Google Scholar]
  24. Rinder C. S., Rinder H. M., Smith B. R., Fitch J. C., Smith M. J., Tracey J. B., Matis L. A., Squinto S. P., Rollins S. A. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. J Clin Invest. 1995 Sep;96(3):1564–1572. doi: 10.1172/JCI118195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Till G. O., Johnson K. J., Kunkel R., Ward P. A. Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites. J Clin Invest. 1982 May;69(5):1126–1135. doi: 10.1172/JCI110548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Till G. O., Morganroth M. L., Kunkel R., Ward P. A. Activation of C5 by cobra venom factor is required in neutrophil-mediated lung injury in the rat. Am J Pathol. 1987 Oct;129(1):44–53. [PMC free article] [PubMed] [Google Scholar]
  27. Varani J., Phan S. H., Gibbs D. F., Ryan U. S., Ward P. A. H2O2-mediated cytotoxicity of rat pulmonary endothelial cells. Changes in adenosine triphosphate and purine products and effects of protective interventions. Lab Invest. 1990 Nov;63(5):683–689. [PubMed] [Google Scholar]
  28. WARD P. A., COCHRANE C. G. BOUND COMPLEMENT AND IMMUNOLOGIC INJURY OF BLOOD VESSELS. J Exp Med. 1965 Feb 1;121:215–234. doi: 10.1084/jem.121.2.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Warner R. L., Paine R., 3rd, Christensen P. J., Marletta M. A., Richards M. K., Wilcoxen S. E., Ward P. A. Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase. Am J Respir Cell Mol Biol. 1995 Jun;12(6):649–661. doi: 10.1165/ajrcmb.12.6.7539274. [DOI] [PubMed] [Google Scholar]
  30. Weisman H. F., Bartow T., Leppo M. K., Marsh H. C., Jr, Carson G. R., Concino M. F., Boyle M. P., Roux K. H., Weisfeldt M. L., Fearon D. T. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science. 1990 Jul 13;249(4965):146–151. doi: 10.1126/science.2371562. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES